Kukje Pharma Co., Ltd. (KRX:002720)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,365.00
+45.00 (1.04%)
At close: Dec 5, 2025
-15.73%
Market Cap 88.88B
Revenue (ttm) 173.80B
Net Income (ttm) 7.14B
Shares Out 20.36M
EPS (ttm) 350.58
PE Ratio 12.45
Forward PE n/a
Dividend 30.00 (0.69%)
Ex-Dividend Date n/a
Volume 97,308
Average Volume 173,005
Open 4,345.00
Previous Close 4,320.00
Day's Range 4,300.00 - 4,380.00
52-Week Range 4,095.00 - 5,770.00
Beta 0.48
RSI 52.15
Earnings Date Nov 13, 2025

About Kukje Pharma

Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones, tetracycline, aminoglycosides, macrolides, other antibiotics, ophthalmic, antifungal and antiviral agents, ophthalmic agents, adrenal corticosteroids, CNS and osteoporotic agents, antihistamines, NSAID... [Read more]

Sector Healthcare
Founded 1959
Employees 248
Stock Exchange Korea Stock Exchange
Ticker Symbol 002720
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.